Search For "central drugs standard"
License required to import, manufacture medical devices
Updated : 5 years, 7 months ago IST
New Delhi [India], December 29 (ANI): Importers and manufacturers required to take licence from the Central Licensing Authority or State Licensing Authority for the import and manufacture of nebulizers, BP monitoring devices, digital thermometers, and glucometer with effect from January 1, s
Read More
Reports that Centre rejected SII, Bharat Biotech's emergency use authorisa
Updated : 5 years, 7 months ago IST
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
Read More
Cabinet approves MoU between India, UK on cooperation in field of medical
Updated : 5 years, 8 months ago IST
New Delhi [India], November 4 (ANI): The Union Cabinet, chaired by Prime Minister Narendra Modi has given its approval for signing a Memorandum of Understanding (MoU) between the Central Drugs Standard Control Organization (CDSCO), India, and the United Kingdom Medicines and Healthcare Pr
Read More
Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers
Updated : 5 years, 9 months ago IST
Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
Read More
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biote
Updated : 5 years, 9 months ago IST
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Read More
Submit previous trial data for Covaxin before rolling out phase III: Drug
Updated : 5 years, 9 months ago IST
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Read More
Drugs control organisation issues guidelines for trial, marketing of vacci
Updated : 5 years, 10 months ago IST
New Delhi [India], September 18 (ANI): The Central Drugs Standard Control Organisation (CDSCO) said the requirements and guidelines to conduct clinical trial or grant of permission for the marketing of new drugs including vaccines are prescribed under New Drugs and Clinical Trials Rules, 201
Read More
COVID-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injec
Updated : 5 years, 11 months ago IST
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
Read More
Drug regulator gets committee approval for nod to clinical trials by Serum
Updated : 6 years ago IST
New Delhi [India], July 31 (ANI): The Subject Expert Committee at Central Drugs Standard Control Organisation (CDSCO) has recommended to the top drug regulator to grant permission to Serum Institute of India (SII) to conduct phase two and three clinical trials in India on a potential COVID-1
Read More
Drug Regulator asks Serum Institute to furnish revised protocol for COVID-
Updated : 6 years ago IST
New Delhi [India], July 29 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has advised the Serum Institute of India (SII) to submit a revised protocol to perform the clinical trials in India for potential COVID-19 vaccine.
Read More
Top drug regulator suspends import license of 19 firms for their COVID-19
Updated : 6 years ago IST
New Delhi [India], July 25 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import licenses of at least 19 firms for their respective COVID-19 test kits after USFDA removed the manufacturer from their list of the product of serology test kits for coronavirus.
Read More
Top drug regulator CDSCO suspends import license of Mumbai-based firm for
Updated : 6 years ago IST
New Delhi [India], July 24 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has suspended the import license of Mumbai-based company--Transasia Bio-Medicals which is providing COVID-19 IgG ELISA kit.
Read More